HCA Healthcare, Inc. (NYSE:HCA) Holdings Cut by Cahaba Wealth Management Inc.

Cahaba Wealth Management Inc. trimmed its stake in HCA Healthcare, Inc. (NYSE:HCA) by 6.2% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 4,660 shares of the company’s stock after selling 308 shares during the quarter. Cahaba Wealth Management Inc.’s holdings in HCA Healthcare were worth $1,894,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Bangor Savings Bank grew its holdings in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter valued at $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC increased its stake in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock valued at $6,407,273 over the last ninety days. 1.60% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $9.06 during trading hours on Friday, reaching $415.54. 1,093,996 shares of the company were exchanged, compared to its average volume of 1,139,995. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a 50-day moving average of $392.18 and a 200 day moving average of $350.18. The firm has a market cap of $108.84 billion, a price-to-earnings ratio of 20.72, a PEG ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same period in the previous year, the company posted $4.29 earnings per share. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s payout ratio is presently 13.16%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Royal Bank of Canada upped their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. Oppenheimer raised their target price on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $365.65.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.